Childhood cancer and its treatment can result in cognitive struggles. St. Jude scientists are studying the risk factors.

Discovery of a metabolic pathways that inhibit memory T cell production has potential for enhancing the immune system’s ability to fight infections and cancers.

St. Jude Children’s Research Hospital has discovered a mechanism that tumors use to switch on protective regulatory T cells, raising the potential for drug treatments that render tumors more vulnerable to cancer immunotherapy.

A pair of research papers from St. Jude Children’s Research Hospital report on a medulloblastoma clinical trial that provides insights to guide treatment and shed light on relapsed disease.

Scientists at St. Jude Children’s Research Hospital have shed light on the mechanisms that underlie how Aspergillus fumigatus activates the inflammasome, with implications for therapeutic development.

Sara Federico, MD, received the NCI award for substantial impact in the field of childhood solid tumors through the development and conduct of clinical trials

The COVID-19 pandemic continues to cause significant illness and death while treatment options remain limited. St. Jude Children’s Research Hospital scientists have discovered a potential strategy to prevent life-threatening inflammation, lung damage a…

Scientists at St. Jude Children’s Research Hospital are included on the Highly Cited Researchers 2020 list, which features some of the world’s most influential researchers.

The St. Jude Children’s Research Hospital inpatient Nurse Residency Program has been accredited by the American Nurses Credentialing Center (ANCC) as a Practice Transition Program.

Researchers have used insight from a comprehensive genomic analysis of neuroblastoma to learn about the process driving one of the most common childhood solid tumors.